COST-EFFECTIVENESS OF GUANFACINE EXTENDED-RELEASE AS AN ADJUNCTIVE THERAPY TO A LONG-ACTING STIMULANT VERSUS LONG-ACTING STIMULANT MONOTHERAPY FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN CANADA

被引：0
|
作者：
Lachaine, J. [1 ]
Sikirica, V [2 ]
Mathurin, K. [1 ]
机构：
[1] Univ Montreal, Montreal, PQ, Canada
[2] Shire Dev LLC, Wayne, PA USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.1251
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH32
引用
收藏
页码：A214 / A214
页数：1
相关论文
共 50 条
  • [41] Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison
    Carlos I. Alatorre
    Virginia Haynes
    Douglas Faries
    Himanshu Upadhyaya
    Douglas Kelsey
    Applied Health Economics and Health Policy, 2013, 11 (3) : 305 - 305
  • [42] Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder
    Cox, Daniel J.
    Mikami, Amori Yee
    Cox, Brian S.
    Coleman, Margaret Taylor
    Mahmood, Aamir
    Sood, Ajay
    Moore, Melissa
    Burket, Roger
    Merkel, R. Lawrence
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2008, 162 (08): : 793 - 794
  • [43] Long-Acting Methylphenidate-OROS in Youths with Attention-Deficit Hyperactivity Disorder Suboptimally Controlled with Immediate-Release MethylphenidateA Study of Cost Effectiveness in The Netherlands
    Adrianne Faber
    Michel van Agthoven
    Luuk J. Kalverdijk
    Hilde Tobi
    Lolkje T. W. de Jong-van den Berg
    Lieven Annemans
    Maarten J. Postma
    CNS Drugs, 2008, 22 : 157 - 170
  • [44] Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison
    Erder, M. Haim
    Xie, Jipan
    Signorovitch, James E.
    Chen, Kristina S.
    Hodgkins, Paul
    Lu, Mei
    Wu, Eric Q.
    Sikirica, Vanja
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2013, 11 (03) : 307 - 307
  • [45] Long-acting methylphenidate-OROS in youths with attention-deficit hyperactivity disorder suboptimally controlled with immediate-release methylphenidate - A study of cost effectiveness in the Netherlands
    Faber, Adrianne
    van Agthoven, Michel
    Kalverdijk, Luuk J.
    Tobi, Hilde
    de Jong-Van den Berg, Lolkje T. W.
    Annemans, Lieven
    Pastma, Maarten J.
    CNS DRUGS, 2008, 22 (02) : 157 - 170
  • [46] The cost-effectiveness of risperidone long-acting injection in the treatment of schizophrenia
    Chue, Pierre
    Chue, James
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (03) : 259 - 269
  • [47] COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE LONG-ACTING INJECTION COMPARED WITH RISPERIDONE LONG-ACTING INJECTION IN THE TREATMENT OF SCHIZOPHRENIA IN NORWAY
    Carroll, S. M.
    Jemiai, N.
    Suter, B.
    O'Donohoe, P.
    Skjoldborg, U.
    Moller, J.
    Kleivenes, O. K.
    Novick, D.
    VALUE IN HEALTH, 2009, 12 (07) : A358 - A358
  • [48] Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
    Coghill, David
    Banaschewski, Tobias
    Zuddas, Alessandro
    Pelaz, Antonio
    Gagliano, Antonella
    Doepfner, Manfred
    BMC PSYCHIATRY, 2013, 13
  • [49] Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
    David Coghill
    Tobias Banaschewski
    Alessandro Zuddas
    Antonio Pelaz
    Antonella Gagliano
    Manfred Doepfner
    BMC Psychiatry, 13
  • [50] Long-acting methylphenidate. An alternative medical therapy for adult patients with attention deficit hyperactivity disorder
    Sobanski, E
    Alm, B
    NERVENARZT, 2005, 76 (11): : 1412 - +
12345